Teva Pharmaceutical Industries Ltd — Quarterly Results & Earnings

₹1.84

-4.93%

Profit Growth YoY-1100.85%Latest quarter

Sales Growth YoY7.66%Latest quarter

Sales CAGR 5Y-51.00%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-1100.85%

🔴 Significant decline

YoY Sales Growth+7.66%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

2.29%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

-10.02

ROE

N/A

ROCE

-18.13%

💡

Growth Analysis

Teva Pharmaceutical Industries Ltd reported YoY profit growth of -1100.85% and revenue growth of 7.66% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -51.00% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Teva Pharmaceutical Industries Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Civil Construction Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.